No association between cSHMT genotypes and the risk of breast cancer in the Nurses' Health Study
Genetic Predisposition to Disease
Methylenetetrahydrofolate Reductase (NADPH2)
Polymorphism, Single Nucleotide
There was no evidence of an association between the cSHMT genotype and breast cancer occurrence. Further research in populations with differing average folate intake may be required to fully understand the interactions of folate nutrition, sequence variation in folate genes and breast cancer risk.